Keywords: Novo Nordisk, Sucampo, Appointments

Senior appointments at Novo Nordisk and Sucampo

Article | 08 September 2011

Print This

The US unit of Danish insulin giant Novo Nordisk (NVO: N) has appointed Eddie Li, as vice president, regulatory affairs, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in